INO

Inovio Pharmaceuticals, Inc. - Common Stock

5.4400
USD
-2.51%
5.4400
USD
-2.51%
3.6400 6.3600
52 weeks
52 weeks

Mkt Cap 497.74M

Shares Out 91.50M

new Chat
Send me real-time posts from this site at my email

Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline

Inovio Pharmaceuticals, Inc. INO announced that it has licensed a veterinary vaccine for the treatment of foot and mouth disease (FMD) to a South Korean animal health company, Plumbline Life Sciences.

Inovio will get milestone payments as well as royalties from Plumbline on product sales of the FMD synthetic vaccine in Asia, excluding Japan. Plumbline will also fund all development activities related to the vaccine.

Per Inovio’s press release, FMD is one of the most infectious diseases affecting farm animals including cattle, swine, sheep and goats, and is therefore a serious threat to global food safety. Considering that the disease can spread rapidly and beyond regional boundaries, there is urgent need to develop vaccines that can...


More